International Consensus on the Evaluation and Management of : Results From a Modified Delphi Survey
Hypothalamic hamartomas (HH) are rare developmental brain lesions frequently associated with medically refractory epilepsy and complex neurobehavioral, cognitive and endocrine comorbidities.
Clinical Scorecard: International Consensus on the Evaluation and Management of Hypothalamic Hamartomas: Results From a Modified Delphi Survey
At a Glance
| Category | Detail |
|---|
| Condition | Hypothalamic hamartomas |
| Key Mechanisms | Developmental brain lesions associated with epilepsy and neurobehavioral, cognitive, and endocrine comorbidities. |
| Target Population | Children with hypothalamic hamartomas and gelastic epilepsy. |
| Care Setting | Pediatric epilepsy centers |
Key Highlights
- Consensus achieved on 82% of evaluated questions regarding diagnosis and management.
- Emphasis on early referral and protocol-driven evaluation.
- Individualized surgical planning based on lesion characteristics.
- Support for a multidisciplinary approach to optimize patient outcomes.
- Involvement of experts from 17 ILAE Level II epilepsy surgery centers.
Guideline-Based Recommendations
Diagnosis
- Utilize a standardized protocol for the evaluation of hypothalamic hamartomas.
Management
- Implement individualized surgical planning based on lesion size and location.
Monitoring & Follow-up
- Regular follow-up to assess treatment outcomes and manage comorbidities.
Risks
- Consider potential complications associated with surgical interventions.
Patient & Prescribing Data
Children with medically refractory epilepsy due to hypothalamic hamartomas.
Multidisciplinary coordination is crucial for optimizing treatment outcomes.
Clinical Best Practices
- Early referral to specialized epilepsy centers.
- Protocol-driven evaluation for consistent diagnosis.
- Collaboration among neurology, surgery, and other specialties.
Related Resources & Content
